This is the classic website, which will be retired eventually. Please visit the modernized instead.
Working… Menu

A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT05323461
Recruitment Status : Active, not recruiting
First Posted : April 12, 2022
Last Update Posted : April 10, 2023
Information provided by (Responsible Party):
Sinocelltech Ltd.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : October 28, 2022
Estimated Study Completion Date : May 1, 2023